Sudarshan Pharma Industries Ltd — Updates, 13-05-2025: Company Update

Sudarshan Pharma has announced a board meeting and resolved to acquire 100% equity (300 shares) of Cibachem General Trading L.L.C., Dubai, at a revised cash consideration of Rs. 55 lakh (or equivalent AED). Cibachem operates in general trading and has reported turnovers of AED 4.99 lakh, 3.51 lakh, and 4.92 lakh over the past three calendar years. This acquisition aims to expand Sudarshan Pharma’s customer base in the Middle East, strengthening its regional presence and growth prospects.